))
Insilico Medicine: A Leader in AI-driven Pharma Innovation
Manage episode 412205627 series 3554501
Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Insilico Medicine uses generative AI for drug discovery and has set the trend for AI in the pharmaceutical industry. They have developed an AI platform to identify novel targets and molecules, significantly reducing the time and cost of the drug discovery process. The company has a pipeline of novel molecules and drugs, with one asset in clinical trials for idiopathic pulmonary fibrosis (IPF). They’ve gained the trust of the pharma industry and have partnerships with big pharma and contract research organizations.
Story Notes:
- Introduction and Background of Insilico Medicine
- Understanding Generative AI
- Insilico Medicine's Approach to Drug Discovery
- The Visionary Leadership of Alex Zhavoronkov
To learn more, visit:
https://boldcapitalpartners.com/
5 에피소드
공유
